What are the recommended adult dosing regimens for Malarone (atovaquone + proguanil) for malaria prophylaxis and treatment, and for Dukoral (oral cholera vaccine) for cholera prevention?

Dosing for Malarone and Dukoral

Malarone (Atovaquone-Proguanil) Dosing

For malaria prophylaxis in adults and children >40 kg, take one tablet (250 mg atovaquone/100 mg proguanil) daily, starting 1-2 days before travel, continuing throughout exposure, and for 7 days after leaving the malaria-endemic area. 1, 2

Prophylaxis Dosing by Weight

• >40 kg (adults): 1 tablet (250 mg/100 mg) daily 3, 1
• 31-40 kg: 3 pediatric tablets daily 2
• 21-30 kg: 2 pediatric tablets daily 2
• 11-20 kg: 1 pediatric tablet daily 2
• <11 kg: Not recommended 1

Treatment Dosing for Uncomplicated Malaria

• Adults >40 kg: 4 tablets (1000 mg atovaquone/400 mg proguanil) once daily for 3 consecutive days 4, 5
• 31-40 kg: 3 tablets once daily for 3 days 5
• 21-30 kg: 2 tablets once daily for 3 days 5
• 11-20 kg: 1 tablet once daily for 3 days 5

Key Timing Principles

• Start 1-2 days before departure to establish tolerance and routine 1, 2
• Continue for only 7 days after leaving the endemic area (shorter than other antimalarials which require 4 weeks) 1, 3
• Take with food or a milky drink to enhance absorption, as dietary fat increases atovaquone bioavailability 2-3 fold 2

Clinical Efficacy

• Prophylactic efficacy is 95-100% against P. falciparum in both immune and non-immune populations 1, 6
• Treatment cure rate exceeds 98% for uncomplicated falciparum malaria 4, 5
• Active against both hepatic and erythrocytic stages, providing causal prophylaxis and eliminating need for extended post-travel dosing 1

---

Dukoral (Oral Cholera Vaccine) Dosing

For adults and children ≥6 years, administer 2 doses with at least 1 week (but no more than 6 weeks) between doses, completing the series at least 1 week before potential cholera exposure. 7

Administration Schedule

• Adults and children ≥6 years: 2 doses separated by 1-6 weeks 7
• Children 2-6 years: 3 doses (specific interval data not provided in available evidence) 7
• Complete vaccination at least 1 week before travel to cholera-endemic areas 7

Preparation and Administration

• Mix the vaccine suspension with buffer solution as directed in package insert 7
• Avoid food and drink for 1 hour before and after vaccine administration 7
• Do not administer within 14 days of antibiotic use, as antibiotics may inactivate the live vaccine strain 7

Important Contraindications and Interactions

• Avoid coadministration with chloroquine, as a previous formulation showed reduced immunogenicity when given together 7
• Separate from antimalarial prophylaxis by appropriate intervals to avoid interference 7
• Not routinely recommended for most travelers, only for those visiting areas with active cholera transmission 7

Target Population

• Recommended for travelers aged 18-64 years going to areas with active cholera transmission (defined as provinces/states with endemic or epidemic cholera within the past year) 7
• Consider for high-risk individuals including those with blood type O, low gastric acidity, or limited access to medical care 7
• Most US travelers do not require cholera vaccination, as they typically do not visit areas with active transmission 7

Duration of Protection

• Protection duration beyond 3 months is unknown for the current formulation 7
• No booster dose recommendations exist at this time due to lack of safety and efficacy data 7

---

Critical Safety Considerations

Malarone

• Well tolerated with minimal adverse effects; most common are headache and abdominal pain at rates similar to placebo 1, 6
• Significantly fewer neuropsychiatric effects than mefloquine and fewer GI effects than chloroquine-proguanil 1
• Contraindicated in severe renal impairment (creatinine clearance <30 mL/min) 1
• Safe in pregnancy is not established; avoid if possible 1

Dukoral

• Generally safe with minimal adverse effects beyond mild diarrhea 7
• Avoid in pregnancy and breastfeeding unless benefits clearly outweigh risks 8
• Store in childproof containers as with all medications 7

Common Pitfall

The most critical error is premature discontinuation of prophylaxis. While Malarone only requires 7 days post-travel (versus 4 weeks for other antimalarials), adherence to this full course is essential to prevent late-emerging parasitemia from hepatic stages 3, 1. The majority of malaria deaths in travelers occur among those who do not complete their prophylactic regimen 3.